Cited by 47Prion Diseases and Protein MisfoldingNeuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Inflammatory response of microglia to prions is controlled by sialylation of PrPSc

Open access
Srivastava, Saurabh, Katorcha, Elizaveta, Makarava, Natallia, Barrett, James P., Loane, David J., Baskakov, Ilia V.·2018·Scientific Reports

Abstract

Neuroinflammation is recognized as one of the obligatory pathogenic features of neurodegenerative diseases including Alzheimer’s, Parkinson’s or prion diseases. In prion diseases, space and time correlations between deposition of disease-associated, pathogenic form of the prion protein or PrP Sc and microglial-mediated neuroinflammation has been established. Yet, it remains unclear whether activation of microglia is triggered directly by a contact with PrP Sc, and what molecular features of PrP Sc microglia sense and respond to that drive microglia to inflammatory states. The current study asked the questions whether PrP Sc can directly trigger activation of microglia and whether the degree of microglia response depends on the nature of terminal carbohydrate groups on the surface of PrP Sc particles. PrP Sc was purified from brains of mice infected with mouse-adapted prion strain 22L or neuroblastoma N2a cells stably infected with 22L. BV2 microglial cells or primary microglia were cultured in the presence of purified 22L. We found that exposure of BV2 cells or primary microglia to purified PrP Sc triggered proinflammatory responses characterized by an increase in the levels of TNFα, IL6, nitric oxide (NO) and expression of inducible Nitric Oxide Synthase (iNOS). Very similar patterns of inflammatory response were induced by PrP Sc purified from mouse brains and neuroblastoma cells arguing that microglia response is independent of the source of PrP Sc. To test whether the microglial response is mediated by carbohydrate epitopes on PrP Sc surface, the levels of sialylation of PrP Sc N-linked glycans was altered by treatment of purified PrP Sc with neuraminidase. Partial cleavage of sialic acid residues was found to boost the inflammatory response of microglia to PrP Sc. Moreover, transient degradation of Iκβα observed upon treatment with partially desialylated PrP Sc suggests that canonical NFκB activation pathway is involved in inflammatory response. The current study is the first to demonstrate that PrP Sc can directly trigger inflammatory response in microglia. In addition, this work provides direct evidence that the chemical nature of the carbohydrate groups on PrP Sc surface is important for microglial activation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-018-29720-z

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Microglia are directly activated by PrPSc in vitro.

    “Moreover, microglia are directly activated by PrPSc in vitro [33,59]; however, such causalities are difficult to prove in vivo.”

    From Loss of Homeostatic Microglia Signature in Prion Diseases (2022) · cites this paper as [59]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 83 · Cited by 47

Authors
Srivastava, S., Katorcha, E., Makarava, N., Barrett, J. P., Loane, D. J., & Baskakov, I. V.
Affiliations
University of Maryland, Baltimore (US)
Corresponding author
Baskakov, Ilia V.
Venue
Scientific Reports
Published
2018-07-27
Volume
8
Issue
1
Pages
11326-11326
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2883337393
Cited by
47
References
83
Citations by year
2026: 1 · 2025: 5 · 2024: 7 · 2023: 2 · 2022: 8 · 2021: 11 · 2020: 9 · 2019: 3 · 2018: 1
FWCI
2.13
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS082308, NS045585)
  • U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI128925)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
prion disease, PrPSc, microglial activation, neuroinflammation, sialylation, N-glycans, sialic acid, neuraminidase, NF-κB signaling, IκBα degradation, TNF-α, interleukin-6, nitric oxide, inducible nitric oxide synthase, BV2 microglial cells
MeSH terms
Animals, Epitopes, Brain, Carbohydrates, Gene Expression Regulation, Humans, Inflammation, Nitric Oxide, Tumor Necrosis Factor-alpha, Interleukin-6, Prion Diseases, Microglia, PrPSc Proteins, N-Acetylneuraminic Acid, Mice, Nitric Oxide Synthase Type II, Primary Cell Culture

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review